Document Detail


Nutritional influence on serum ammonia in young patients receiving sodium valproate.
MedLine Citation:
PMID:  3081337     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hyperammonemia is a common side effect of valproic acid (VPA) therapy. This study was designed to investigate a potential nutritional influence on serum ammonia levels during VPA therapy. In 10 VPA-treated young patients (5 receiving monotherapy, 5 receiving VPA-primidone polytherapy), venous serum ammonia, triglycerides, and cholesterol were measured on 3 consecutive days as follows: (a) after a 13-h overnight fast; (b) 2 h after an oral fat load with butter (1.2 g fat/kg body weight); and (c) 2 h after an oral protein load with fresh cheese (1 g protein/kg body weight). Ten young adults served as controls. After protein load VPA patients had significantly higher serum ammonia levels than controls (mean: 194 vs. 75 micrograms/dl in controls; p less than 0.006). Ammonia values were higher after protein load than after fat load or after fasting (p less than 0.0001). Patients receiving polytherapy had higher ammonia levels than patients receiving monotherapy (not significant). There was no correlation to the height of serum VPA levels. Clinical symptoms attributable to hyperammonemia (vomiting, apathy) were found in only one patient, and her serum ammonia was as high as 426 micrograms/dl. Triglycerides and cholesterol did not show any VPA-induced differences. We assume that VPA alters the short-term regulation of ureasynthesis. We recommend the avoidance of high protein intake in patients receiving VPA therapy, especially in young patients receiving polytherapy or comedication, or in risk situations like serious infections.
Authors:
M C Laub
Related Documents :
20833077 - Anti-inflammatory properties of high-density lipoprotein cholesterol in chronic hemodia...
3386817 - Practical application of a low-protein diet for parkinson's disease.
2929527 - Efficacy of a nonrestricted fat diet in patients with cystic fibrosis.
2408467 - Correction of uremic cellular injury with a protein-restricted amino acid-supplemented ...
12865257 - Abnormalities of leptin and ghrelin regulation in obesity-prone juvenile rats.
20835897 - Sleeve gastrectomy induces weight loss in diet-induced obese rats even if high-fat feed...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Epilepsia     Volume:  27     ISSN:  0013-9580     ISO Abbreviation:  Epilepsia     Publication Date:    1986 Jan-Feb
Date Detail:
Created Date:  1986-03-28     Completed Date:  1986-03-28     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  2983306R     Medline TA:  Epilepsia     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  55-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Ammonia / blood*
Cholesterol / blood
Diet*
Dietary Proteins / administration & dosage
Female
Humans
Male
Triglycerides / blood
Valproic Acid / adverse effects,  therapeutic use*
Chemical
Reg. No./Substance:
0/Dietary Proteins; 0/Triglycerides; 57-88-5/Cholesterol; 7664-41-7/Ammonia; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Risk of recurrence after an initial unprovoked seizure.
Next Document:  Clinical trial with an experimental taurine derivative, taltrimide, in epileptic patients.